Search companies

Live

Tuesday, 17 November 2026 · 582 Summaries Today

S&P/ASX 200 · 8,883.20 (-1.79%)

EZZ Receipts Fall 38% As Cash Outflow Narrows Sharply

EZZ Life Science Holdings Limited (EZZ) · Consumer discretionary

EZZ: $0.305 -1.61% · MC: $14M

EZZ Life Science Holdings reported customer receipts down approximately 38% year-on-year to about $7 million in Q1 FY27, reflecting softer sales across Chinese e-commerce platforms, while net operating cash outflow narrowed to about $0.4 million from more than $3 million a year earlier. EAORON skincare sales rose approximately 141% year-on-year, though the company says the brand remains a modest contributor to group revenue; potential product returns worth approximately $4 million remain under discussion with customers. EZZ ended the quarter with about $9 million in cash and no debt, excluding lease liabilities.

Source announcements: 2026-10-30 16:57 to 2026-10-30 16:57 Sydney time
Story updated 2026-10-30 17:05 Sydney time
SourcesQuarterly Activity and Cashflow Report
Comments